Minimizing $50-60B loss in annual failed Cancer Clinical Trials by Optimizing Patient Identification and Recruitment Strategies
Clinical trials are crucial in the development of new cancer treatments, but the staggering loss of $50-$60 billion annually due to failed oncology clinical trials emphasizes the need for improved oncology patient identification and recruitment strategies. A recent review found patient participation in oncology trials to be low, ranging from 2% to 8% of adult […]